Verapamil Hcl Tablets Suppliers & Bulk Manufacturers
Available Forms: Sustained-release tablets
Available Strengths: 240 mg once daily
Reference Brands: Covera-HS®
Category:
Drugs Using Osmotic Pump Systems
Covera-HS (verapamil) inhibits calcium influx into cardiac and vascular smooth muscle cells, leading to vasodilation and reduced heart rate. It effectively manages hypertension, angina, and arrhythmias. Benefits include blood pressure control, decreased cardiac workload, and symptom relief, supporting cardiovascular health when used appropriately under medical supervision.
Verapamil HCl tablets is available in Sustained-release tablets
and strengths such as 240 mg once daily.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Verapamil HCl tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Verapamil HCl tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Covera-HS® (verapamil HCl) is regulated in the EU and US, supported by dossiers demonstrating safety, efficacy, and manufacturing quality compliant with GMP and MDR standards. In the US, FDA approval involved clinical validation, safety assessments, and GMP compliance. In the EU, CE marking certifies conformity with MDR standards. These formulations undergo validation, stability testing, and audits, with comprehensive documentation including safety profiles, clinical data, and manufacturing practices.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing